Comparison · NCT01805089-9030b4fd
Melatonin vs Placebo: Compliance
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Melatonin vs Placebo: Compliance. Trial comparisons, record NCT01805089-9030b4fd. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01805089-9030b4fd
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.896 | 0.778 | 0.955 | wilson | |
| Risk in group 2 | 0.915 | 0.801 | 0.966 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0191 | -0.147 | 0.109 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.979 | 0.86 | 1.12 | log | |
| Odds ratio, group 1 over group 2 | 0.8 | 0.201 | 3.18 | log | |
| Number needed to treat, for one fewer participant with the outcome on Melatonin than on Placebo | 52.5 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Melatonin | Taken orally, once per day, at/around 9:00pm~Melatonin | 43 | 48 | OG000 |
| Group 2 | Placebo | Taken orally, once per day, at/around 9:00pm~Placebo | 43 | 47 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Compliance
- Description
- To evaluate compliance with a 4 month course of melatonin. Compliance was assessed via pill counts.
- Time frame
- 4 months
- Population
Source ClinicalTrials.gov
Trial
- Title
- Melatonin Versus Placebo in Breast Cancer
- NCT number
- NCT01805089
- Phases
- EARLY_PHASE1
- Conditions
- Breast Cancer
- Interventions
- Melatonin 3 mg
- Lead sponsor
- Dana-Farber Cancer Institute
- Results first posted
- 2015-02-23
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01805089?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01805089-9030b4fd